BioCardia, Inc. - Common Stock (BCDA)

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.

BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering.

BioCardia just reported results for the second quarter of 2024.

BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family.